FDA vet Beitz joins Hyman, Phelps & McNamara
Plus: Codetta names Corriveau as CEO and updates from Nucleix and Leo Pharma
Law firm Hyman, Phelps & McNamara hired Julie Beitz as principal drug regulatory expert. A 30-year veteran of FDA’s Center for Drug Evaluation and Research, Beitz was director of the Office of Immunology and Inflammation in the Office of New Drugs when she retired in July.
Biomarker company Codetta Biosciences Inc. named Jacques Corriveau as CEO. Corriveau was president and CEO of Ultivue Inc...